Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

ClinicalTrials.gov ID: NCT01686152

Public ClinicalTrials.gov record NCT01686152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis of the Face or Balding Scalp

Study identification

NCT ID
NCT01686152
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
589 participants

Conditions and interventions

Interventions

  • Imiquimod Cream, 3.75% Drug
  • Zyclara® Drug
  • Vehicle of Test Product Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
Jul 31, 2013
Completion
Jul 31, 2013
Last update posted
Nov 23, 2020

2012 – 2013

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Radiant Research, Inc. Tucson Arizona 85710
Encino Research Center Encino California 91436
Dermatology Research Associates Los Angeles California 90045
Northern California Research Sacramento California 95821
Skin Surgery Medical Group, Inc. San Diego California 92117
Longmont Clinic, PC Longmont Colorado 80501
Visions Clinical Research Boynton Beach Florida 33472
Tampa Bay Medical Research Clearwater Florida 33761
Jacksonville Center for Clinical Research Jacksonville Florida 32216
International Dermatology Research, Inc. Miami Florida 33144
Tory Sullivan, M.D., P.A. North Miami Beach Florida 33162
Park Avenue Dermatology, PA Orange Park Florida 32073
Leavitt Medical Associates of Florida dba Ameriderm Research Ormond Beach Florida 32174
Radiant Research, Inc. Pinellas Park Florida 33781
MedaPhase, Inc. Newnan Georgia 30263
Altman Dermatology Associates Arlington Heights Illinois 60005
The Indiana Clinical Trials Center Plainfield Indiana 46168
Dermatology Specialists Research LLC Louisville Kentucky 40202
Radiant Research, Inc. Cincinnati Ohio 45249
Oregon Medical Research Center, PC Portland Oregon 97223
Philadelphia Institute of Dermatology Fort Washington Pennsylvania 19034
Omega Medical Research Warwick Rhode Island 02886
Research Across America Dallas Texas 75234

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01686152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01686152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →